Explore
Trendline
FDA Approves Precision Fermentation Animal Protein for Pet Food, Impacting Pet Nutrition
FDA Approves Precision Fermentation Animal Protein for Pet Food, Impacting Pet Nutrition
Read More
Trendline
Lantern Pharma's HARMONIC Trial Receives FDA Support for Protocol Amendments in NSCLC Treatment
Lantern Pharma's HARMONIC Trial Receives FDA Support for Protocol Amendments in NSCLC Treatment
Read More
Trendline
Opentrons Introduces Compliance Ready Software for Flex Lab Robots to Enhance Regulatory Adherence
Opentrons Introduces Compliance Ready Software for Flex Lab Robots to Enhance Regulatory Adherence
Read More
Trendline
FDA Accepts sNDA and Grants Priority Review to AQNEURSA for Ataxia-Telangiectasia
FDA Accepts sNDA and Grants Priority Review to AQNEURSA for Ataxia-Telangiectasia
Read More
Trendline
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn to Lead Clinical and Regulatory Strategy
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn to Lead Clinical and Regulatory Strategy
Read More
Trendline
FDA Accepts ImmunityBio's Supplemental BLA for ANKTIVA Plus BCG in Bladder Cancer Treatment
FDA Accepts ImmunityBio's Supplemental BLA for ANKTIVA Plus BCG in Bladder Cancer Treatment
Read More
AP News
New Jell-O products swap fruit juice for artificial colors
Jell-O is getting a line of products made without synthetic colors or artificial sweeteners to meet increasing consumer demand for natural ingredients
Read More
Trendline
USDA Seeks Public Input on Future Biotechnology Regulation Amid Evolving Policies
USDA Seeks Public Input on Future Biotechnology Regulation Amid Evolving Policies
Read More
Trendline
Penn State Extension Hosts Free Agriculture Camp for Youth in Selinsgrove
Penn State Extension Hosts Free Agriculture Camp for Youth in Selinsgrove
Read More
Trendline
ImmunityBio Secures U.S. Agreement for Tokyo Strain of BCG to Address Bladder Cancer
ImmunityBio Secures U.S. Agreement for Tokyo Strain of BCG to Address Bladder Cancer
Read More
Trendline
Target to Remove Artificial Colors from Cereals by May 2026 Amid Health Concerns
Target to Remove Artificial Colors from Cereals by May 2026 Amid Health Concerns
Read More
Trendline
FDA Approves AstraZeneca's Baxfendy, a New Class of Hypertension Drug
FDA Approves AstraZeneca's Baxfendy, a New Class of Hypertension Drug
Read More